You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety

Alerts

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
558 Programmed death (PD)-1 and PD-ligand-1 inhibitors in the treatment of non-small cell lung cancer: a systematic review of their efficacy and safety
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address